InvestorsHub Logo
Followers 7
Posts 392
Boards Moderated 0
Alias Born 01/16/2014

Re: None

Wednesday, 04/02/2014 7:16:15 AM

Wednesday, April 02, 2014 7:16:15 AM

Post# of 27076
For my own DD I've often compared NRTI to MuslePharm, to get an idea of where we could be going. The latter company has just published a revenue of 110M in 2013, coming from 3M in 2010.

Gross margin is comparable, which is good.

As NRTI will likely beat 3M in 2014, one gets an idea of where we could be in 2017. That's still without MJ.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.